Schildklierhormoon en ontwikkeling:
het belang van transporters en dejodases
Proefschrift
Ter verkrijging van de graad van doctor
aan de Erasmus Universiteit Rotterdam
op gezag van de rector magnificus
prof. dr. H.G. Schmidt
en volgens besluit van het College voor Promoties
De openbare verdediging zal plaatsvinden op
woensdag 30 juni 2010 om 15.30 uur
door
Willem Eduard Visser
Geboren te Dordrecht
The studies presented in this thesis were conducted at the Dept of Internal Medicine,
Erasmus MC, Rotterdam, The Netherlands. They were supported by TOP grant 9120.6093
from the Netherlands Organization for Health Research and Development (ZonMW).
The studies described in Chapters 6 and 12 were performed in close collaboration with
the Dept of Bioinformatics and Biomics of the Erasmus MC. The studies presented in
Chapter 12 were performed in close collaboration with the Dept of Endocrinology and
Metabolism, Leiden University Medical Center, Leiden. Chapter 13 was performed in
close collaboration with the Dept of Genetics and Dept of Pathology, Erasmus MC; RIVM,
Bilthoven; DNAge, Leiden, The Netherlands; Dept of Comparative Endocrinology, Catholic
University Leuven, Leuven, Belgium; Edison Biotechnology Institute, Athens, Ohio.
The studies presented in Chapters 9-11 were based on a collaboration with many institutions
caring for subjects with mental retardation and with many laboratories, all in The
Netherlands. They are listed in the acknowledgments of Chapter 9.
The studies presented in Chapter 2 were done in collaboration with the Dept of Pathology,
Anatomy and Cell Biology, Thomas Jefferson University, Philadelphia, Pennsylvania;
School of Biological Sciences, Royal Holloway University of London, London, UK; Dept
of Biopharmaceutical Sciences, University of California, San Francisco, California; Dept of
Cell Biology, Erasmus MC.
The studies presented in Chapter 5 were done in collaboration with the Institute of
Biomedical Sciences, University of Chile, Casilla, Chile; Dept of Pediatrics, University
Hospital Lund, Lund, Sweden; Dept of Child Neurology, VU Medical Center, Amsterdam;
Dept of Child Neurology, University Medical Center Groningen, Groningen.
The studies presented in Chapter 6 were performed in collaboration with the Dept of
Clinical Genetics, Erasmus MC.
The studies presented in Chapter 7 were performed in collaboration with the Institute
of Pharmacology and Toxicology, Justig Liebig University of Giessen, Giessen, Germany.
The studies described in Chapter 10 were done in collaboration with the Dept of Child
Neurology, Erasmus MC-Sophia.
Contents
Chapter 1 General introduction
Chapter 2 Evidence for a homodimeric structure of human monocarboxylate
transporter 8
Chapter 3 Ubiquitination and turnover of the human monocarboxylate
transporter 8
Chapter 4 The thyroid hormone transporters MCT8 and MCT10 transport the
affinity-label N-bromoacetyl-[125I]T3 but are not modified by it
Chapter 5 Novel pathogenic mechanism suggested by ex vivo analysis of
MCT8 (SLC16A2) mutations
Chapter 6 Pathogenesis of psychomotor retardation by mutation of MCT8;
insights from expression profiling of human fibroblasts
Chapter 7 Study of the transport of thyroid hormone by transporters of the
SLC10 family
Chapter 8 Transport of thyroxine and 3,3’,5-triiodothyronine in human
umbilical vein endothelial cells
Chapter 9 Thyroid state in a large cohort of patients with mental retardation:
the TOP-R (Thyroid Origin of Psychomotor Retardation) study
Chapter 10 Novel monocarboxylate transporter 8 (MCT8) mutations in a
cohort of patients with unexplained mental retardation
Chapter 11 Mutations in the type 2 (DIO2) and type 3 (DIO3) deiodinases in
patients with unexplained mental retardation
Chapter 12 Physiological thyroid hormone levels regulate numerous skeleta muscle transcripts
Chapter 13 Thyroid hormone signaling is suppressed in progeria and normal
aging
Chapter 14 General discussion
Summary/samenvatting
List of publications
Dankwoord
Curriculum vitae
Introduction
Thyroid hormone, which is the common name for the prohormone T4 (3,5,3’,5’-tetraiodothyronine;
thyroxine) and the bioactive hormone T3 (3,5,3’-triiodothyronine), is
indispensable for normal development and metabolism of all tissues. Its effects on metabolism
are clearly illustrated by the clinical manifestations in primary thyroid diseases.
In hypothyroidism, symptoms such as cold intolerance, constipation, weight gain and
bradycardia result from a generalized slowing of metabolic processes. In contrast, heat
intolerance, weight loss and increased heart rate which are observed in patients with
hyperthyroidism are explained by an increased metabolism. The prerequisite of thyroid
hormone for normal development is clearly exemplified by patients with cretinism.
Insufficient supply of iodine, which is a principal component of thyroid hormone, during
critical periods of development may result in severe and permanent growth impairments,
deafness, motor and mental retardation.
Clinical effects of an altered thyroid state arise from changes in thyroid hormone
physiology at the cellular level. Thyroid hormone homeostasis requires adequate function
of transporter proteins, deiodinating enzymes and nuclear receptors at the level of
thyroid hormone target tissues.
Thyroid hormone synthesis
Thyroid hormone is produced by the thyroid gland, which is located ventrocaudal of the
thyroid cartilage. Histologically, the thyroid is mainly composed of spheric follicles. Each
follicle is constituted of a colloid lumen surrounded by epithelial cells or thyrocytes. A
smaller population of different cells, C-cells, are dispersed between the follicles and are
involved in the Ca2+-homeostasis. Thyroid hormone synthesis is a multi-step process
which takes place in the follicles.
Because iodide is a principal component of thyroid hormone, sophisticated mechanisms
ensure efficient handling of this trace element. Iodide transport across the basolateral
membrane of the thyrocyte is facilitated by the Na/I symporter (NIS; SLC5A5).
The apical iodide flux into the colloid lumen is mediated, at least partially, by pendrin
(PDS; SLC26A4), although other transporter proteins may also play a role (1). Once in
the colloid, iodide is oxidized by thyroperoxidase (TPO). This reaction requires hydrogen
peroxide, which is generated by the dual oxidase type 2 (DUOX2). The maturation
factor DUOXA2 is needed for proper function of DUOX2. The oxidized iodide is rapidly
incorporated by TPO into specific tyrosyl residues of thyroglobulin (TG). This organification
reaction results in the formation of mono- and diiodotyrosines (MIT and DIT). TPO
also catalyzes the coupling of iodotyrosines to form T3 and T4 as well as some other
Table 1. Characteristics of the iodothyronine deiodinases.
D1 D2 D3
Preferred substrates rT3, sulfated
iodothyronines
T4, rT3 T3, T4
Km 10-7, 10-6 10-9 10-9
Tissue expression Liver, kidney, thyroid Brain, pituitary, brown
adipose tissue, muscle
Brain, fetal tissues
Physiological role Clearance of rT3 and
sulfated iodothyronines,
production of serum T3
Local T3 production Clearance of T3 and T4
Fig. 3. Model of TH regulation in brain. Transporters (paired ovals) are required for uptake and release of
T3 and T4. The deiodinases (circles) activate or inactivate TH. The type 2 deiodinase (D2) converts T4 to T3,
thereby activating TH, whereas the type 3 deiodinase (D3) degrades T3 to T2. Ultimately, T3 binds to the
nuclear TH receptor (TR) and modulates gene expression of T3-target genes.
Chapter 4
The thyroid hormone transporters
MCT 8 and MCT 10 transport the
affinity-label N-bromoacetyl-[125I]
T3 but are not modified by it
Fig. 2. Influence of 10 μM concentrations of T3, T4, BrAcT3 and Triac on T3 (A) and T4 (C) uptake mediated
by hMCT8 and on T3 (B) and T4 (D) uptake mediated by hMCT10.
Chapter 14
General discussion
Part of this chapter is based on
Thyroid hormone transporters: the knowns and the unknowns
‘’There can be little question that the thyroid hormones must ultimately enter the tissue
cells (…)’’ (1). This statement formulated some 50 years ago is still a basic principle for
understanding thyroid hormone (TH) action. However, the concept about the underlying
mechanism for tissue uptake of TH has dramatically changed. While Robins and Rall
were convinced that TH traversed the plasma membrane via diffusion, it is currently
beyond doubt that transporter proteins are required for plasma membrane transport
of TH (2, 3).
The well-known effects of TH on development and metabolism are ultimately the
result of changes in signaling pathways at the cellular level. Many actions of TH are
mediated by changes in gene transcription, when the bioactive hormone T3 binds to its
receptors (TRs) which function as transcription factors (4). Deiodinating enzymes regulate
intracellular concentrations of T3. The type 2 deiodinase (D2) converts the precursor
T4 to T3, while the type 3 deiodinase degrades T4 to rT3 and T3 to 3,3’-T2 (5).
The prerequisite for the intracellular processes of deiodination and genomic actions
of TH is the translocation of the hormone across the plasma membrane. Since the main
focus of this thesis concerned TH transport and TH transporters protein, we first describe
established concepts of TH transport (the knowns). Next, we discuss several
Transporters: The Knowns
TH transport processes
It has been known for a long time that TH accumulates in tissues. These early
Transporters: The Unknowns
The progress made in the understanding of cellular TH transport in recent years has also
increased our awareness that we are just beginning to recognize the complexity of this
aspect of TH homeostasis. In the following sec
Metabolism and action of thyroid hormone
TH regulation during aging
Endocrine systems change during aging. The resemblance of clinical symptoms of hypothyroidism
with features of aging has been recognized for a long time (104). Thyroid
function in humans decreases during life and it is under debate whether elderly people
with subclinical hypothyroidism should be
Conclusion
Life is getting complicated in the world of local TH regulation. In addition to the intricate
regulatory mechanisms of the deiodinases, the discovery of specific TH transporters, of
which MCT8 is currently the most prominent, has expanded our knowledge about the
players involved in TH homeostasis. It is exciting to realize that there are still numbers
of unknown TH transporters and other proteins involved in local TH homeostasis, and
related syndromes. They just need to be discovered
Summary 279
Thyroid hormone is crucial for normal development and function of virtually all tissues.
The thyroid gland secretes predominantly the prohormone T4 and to a lesser extent the
bioactive hormone T3. The net effects of thyroid hormone are exerted at the cellular
level. Cellular thyroid hormone homeostasis is regulated at different levels: a) thyroid
hormone transporters mediate transport of the hormone across the plasma membrane;
b) different deiodinating enzymes activate T4 to T3 or ‘inactivate’ these hormones and
c) thyroid hormone receptors affect gene expression of T3-target genes upon binding
or release of T3.
Primary diseases of the thyroid gland may affect thyroid hormone production. In
hypothyroidism, decreased thyroid hormone production results in clinical symptoms
such as weight gain and cold-intolerance. Opposite clinical features are
Volledig artikel (totaal 311 pag. = incl. alle referenties)
http://publishing.eur.nl/ir/repub/asset ... Edward.pdf
